PAR-24-172 - NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Renewal / Resubmission / Revision Application Due Date Correction to PAR-24-172 "NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)" NOT-HL-24-011 NHLBI Apr 15, 2024 Jul 13, 2026 R33

For technical issues E-mail OER Webmaster